Publications

Cross-talk between iNKT cells and CD8 T cells in the spleen requires the IL-4/CCL17 axis for the generation of short-lived effector cells

Valente M, Dölen Y, van Dinther E, Vimeux L, Fallet M, Feuillet V, Figdor CG. Proc Natl Acad Sci U S A., 2019 , 116, 25816-25827, PMID: 31796596

Blockade of beta-Adrenergic Receptors Improves CD8(+) T-cell Priming and Cancer Vaccine Effic

Clara Daher, Lene Vimeux, Ralitsa Stoeva, Elisa Peranzoni, Georges Bismuth, Elisabeth Wieduwild, Bruno Lucas, Emmanuel Donnadieu, Nadège Bercovici, Alain Trautmann, Vincent Feuillet Cancer Immunol Res., 2019 , 7, 1849-1863, PMID: 31527069

Monalizumab: inhibiting the novel immune checkpoint NKG2A

van Hall, T; Andre, P and Co J Immunother Cancer. , 2019 , 7, PMID: 31623687

Therapeutic blockade of activin-A improves NK cell function and antitumor immunity

Rautela, J; Dagley, LF; and Co Sci Signal, 2019 , 12, PMID: 31455725

Imbalance of Circulating Innate Lymphoid Cell Subpopulations in Patients With Septic Shock

Carvelli J, Piperoglou C, Bourenne J, Farnarier C, Banzet N, Demerlé C, Gainnier M, Vély F. Front Immunol., 2019 , 10:2179, PMID: 31616411

The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF

Vetters J, van Helden MJ, Wahlen S, Tavernier SJ, Martens A, Fayazpour F, Vergote K, Vanheerswynghels M, Deswarte K, Van Moorleghem J, De Prijck S, Takahashi N, Vandenabeele P, Boon L, van Loo G, Vivier E, Lambrecht BN, Janssens S. J Exp Med., 2019 , pii: jem.20182164. , PMID: 31296735

Inherited IL-18BP deficiency in human fulminant viral hepatitis

Belkaya S, Michailidis E, Korol CB, Kabbani M, Cobat A, Bastard P, Lee YS, Hernandez N, Drutman S, de Jong YP, Vivier E, Bruneau J, Béziat V, Boisson B, Lorenzo-Diaz L, Boucherit S, Sebagh M, Jacquemin E, Emile JF, Abel L, Rice CM, Jouanguy E, Casanova JL. J Exp Med., 2019 , pii: jem.20190669, PMID: 31213488

Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2

Cherfils-Vicini J, Iltis C, Cervera L, Pisano S, Croce O, Sadouni N, Győrffy B, Collet R, Renault VM, Rey-Millet M, Leonetti C, Zizza P, Allain F, Ghiringhelli F, Soubeiran N, Shkreli M, Vivier E, Biroccio A, Gilson E. EMBO J., 2019 , 38(11). pii: e100012, PMID: 31000523

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity

Gauthier L, Morel A, Anceriz N, Rossi B, Blanchard-Alvarez A, Grondin G, Trichard S, Cesari C, Sapet M, Bosco F, Rispaud-Blanc H, Guillot F, Cornen S, Roussel A, Amigues B, Habif G, Caraguel F, Arrufat S, Remark R, Romagné F, Morel Y, Narni-Mancinelli E, Vivier E. Cell, 2019 , pii: S0092-8674(19)30460-X. doi: 10.1016/j.cell.2019.04.041, PMID: 31155232

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Perrot I, Michaud HA, Giraudon-Paoli M, Augier S, Docquier A, Gros L, Courtois R, Déjou C, Jecko D, Becquart O, Rispaud-Blanc H, Gauthier L, Rossi B, Chanteux S, Gourdin N, Amigues B, Roussel A, Bensussan A, Eliaou JF, Bastid J, Romagné F, Morel Y, Narni-Mancinelli E, Vivier E, Paturel C, Bonnefoy N. Cell Rep., 2019 , 27(8):2411-2425.e9. doi: 10.1016/j.celrep.2019.04.091, PMID: 31116985